Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 2361 McGaw Ave IRVINE CA 92614 |
Tel: | N/A |
Website: | https://www.pro-dex.com |
IR: | See website |
Key People | ||
Richard L. Van Kirk President, Chief Executive Officer, Chief Operating Officer, Director | Alisha K. Charlton Chief Financial Officer, Corporate Secretary |
Business Overview |
Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The Company has patented adaptive torque-limiting technology and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Company's medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property). |
Financial Overview |
For the six months ended 31 December 2023, Pro-Dex Inc revenues increased 10% to $24.5M. Net loss totaled $115K vs. income of $4M. Revenues reflect Repairs segment increase of 69% to $7.3M, Medical devices segment increase of 1% to $16.8M. Net loss reflects Realized gain on sale of marketable equi decrease from $2.7M (income) to $0K, General and administrative expenses increase of 11% to $2.2M (expense). |
Employees: | 146 as of Jun 30, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $66.11M as of Dec 31, 2023 |
Annual revenue (TTM): | $48.24M as of Dec 31, 2023 |
EBITDA (TTM): | $7.33M as of Dec 31, 2023 |
Net annual income (TTM): | $5.00M as of Dec 31, 2023 |
Free cash flow (TTM): | $3.02M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $4.98M as of Dec 31, 2023 |
Shares outstanding: | 3,511,253 as of Feb 7, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |